Matthias Pinter works at the Medical University of Vienna, where he also received both his MD and PhD. He is board-certified for Internal Medicine, Gastroenterology & Hepatology, and Intensive Care Medicine. He is leading the liver cancer program and research group at the Division of Gastroenterology & Hepatology, and is manager of the hepatobiliary tumor board at the Medical University of Vienna. Currently, he is also the head of the working group “Gastrointestinal Oncology” of the Austrian Society of Gastroenterology & Hepatology.
His main research interests include the systemic treatment of hepatocellular carcinoma, particularly the identification of prognostic markers and score as well as the development of strategies to improve the efficacy of systemic therapies. To broaden his knowledge and expertise in basic research and experimental oncology, he worked as a research fellow and postdoc at renowned institutions, including the University of Bern in Switzerland and the Massachusetts General Hospital/Harvard Medical School in the United States. He has published numerous original papers and review articles on liver cancer in prestigious peer-reviewed journals covering the categories Oncology, Gastroenterology & Hepatology, and Radiology.